Validated LC-MS/MS method for the determination of sarpogrelate in human plasma: application to a pharmacokinetic and bioequivalence study in Chinese volunteers

J Pharm Biomed Anal. 2010 Nov 2;53(3):546-51. doi: 10.1016/j.jpba.2010.03.025. Epub 2010 Mar 30.

Abstract

A rapid and sensitive liquid chromatography-tandem mass spectrometry (LC-MS/MS) method was established for the determination of sarpogrelate in human plasma. One-step protein precipitation with acetonitrile was used to extract the analytes from the plasma. Sarpogrelate and tramadol (internal standard, I.S.) were separated on a Venusil MP-C(18) column within 1.7 min, using acetonitrile:ammonium acetate (10 mM, pH 6.8) (55:45, v/v) as mobile phase at a flow rate of 1.2 mL/min with an approximately 1:1 split entering the mass spectrometer. Detection was performed on electrospray positive ionization mass spectrometry by multiple reaction monitoring of the transitions of sarpogrelate at m/z 430.3-->135.3 and of I.S. at m/z 264.1-->58.0. The assay was validated over the concentration range of 1-1000 ng/mL with a lower limit of quantitation (LLOQ) of 1 ng/mL using 50 microL of plasma. The intra- and inter-day precision (relative standard deviation, R.S.D.) were <or=6.4% and <or=5.4%, respectively, with accuracy (relative error, R.E.) in the range 0.5-3.6%. The method was successfully applied to a pharmacokinetic and bioequivalence study enrolling 22 Chinese volunteers administered sarpogrelate tablets.

Publication types

  • Randomized Controlled Trial
  • Research Support, Non-U.S. Gov't
  • Validation Study

MeSH terms

  • Adult
  • Chromatography, Liquid / methods*
  • Cross-Over Studies
  • Humans
  • Male
  • Reproducibility of Results
  • Serotonin Antagonists / blood*
  • Succinates / blood*
  • Succinates / pharmacokinetics
  • Tandem Mass Spectrometry / methods*
  • Therapeutic Equivalency

Substances

  • Serotonin Antagonists
  • Succinates
  • sarpogrelate